(Q52648282)

English

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.

scientific article published in December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. (English)

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Francesca Romana Mauro

10

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

13

object named as

Robin Foà

1 reference

Europe PubMed Central

5 May 2018

Gianluca Gaidano

12

object named as

Gianluca Gaidano

1 reference

Europe PubMed Central

5 May 2018

Sabina Chiaretti

1

object named as

Sabina Chiaretti

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Alfonso Piciocchi

5

object named as

Alfonso Piciocchi

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Ilaria Del Giudice

3

object named as

Ilaria Del Giudice

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Marilisa Marinelli

2

object named as

Marilisa Marinelli

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

11

object named as

Anna Guarini

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

7

object named as

Marco Vignetti

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

4

object named as

Silvia Bonina

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Valeria Di Maio

9

object named as

Valeria Di Maio

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

author name string

Davide Rossi

8

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

publication date

1 December 2014

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Leukemia & Lymphoma

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

55

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

12

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

2785-2792

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1 mutations in CLL associated with trisomy 12.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

TP53 mutation and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.898760

21 January 2018

Identifiers

10.3109/10428194.2014.898760

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/24597984

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52648282&oldid=1846274615"